𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VAD or VMBCP in severe multiple myeloma

✍ Scribed by Dr M. Monconduit; J. F. Menard; J. L. Michaux; X. Le Loet; J. F. Bernard; B. Grosbois; J. P. Pollet; I. Azais; J. Ph. Laporte; C. Doyen; A. De Gramont; M. Wetterwald; B. Duclos; L. Euller-Ziegler; A. M. Peny

Book ID
114713062
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
521 KB
Volume
80
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VAD chemotherapy—toxicity and efficacy—i
VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies
✍ Dr H. Anderson; J. H. Scarffe; M. Lambert; D. B. Smith; C. C. Chan; G. Chadwick; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Thirty-three patients with multiple myeloma (11 untreated, 15 refractory and seven relapsed patients) have received vincristine and adriamycin infusion therapy with oral dexamethasone (VAD). The median number of course received was five. In addition 16 patients with lymphoid malignancy have received